You searched for "DMO"
Moorfields Manual of Ophthalmology
1 February 2016
| Indira Madgula
|
Ophthalmology, Emergency Ophthalmology, Neuro-Ophthalmology, Paediatric Ophthalmology / Strabismus
The second edition of MMO edited by Timothy Jackson is a very handy practical resource for use in the eye casualty by doctors of all grades and nurse practitioners. It is a user-friendly, well presented manual, comprising 14 sections followed...
The last three patients: general medicine (Patient Two)
5 June 2023
| Jonathan Rees (Prof)
|
Ophthalmology
For the second reflection in this series (see Patient One here), Professor Jonathan Rees recounts his experiences of the last patient he saw as a medical registrar, telling the tragic story of a young man’s death and the risks that...
Effect of cataract surgery on inflammation control and vision in uveitis patients
1 June 2019
| Ivan Yip
|
Cataract and Refractive
|
cataract surgery, phacoemulsification, uveitis, vision impairment
This retrospective longitudinal study from Moorfields, London, UK compared uveitis recurrence rates and vision loss in 309 eyes of uveitis patients post cataract surgery to 300 control uveitis patients. Cataract is a common complication associated with uveitis and leads to...
Diabetic Macular Oedema
1 December 2013
| Pouya Alaghband
Diabetes mellitus is a metabolic disorder that affects the metabolism of all three categories of carbohydrates, lipids and proteins. This condition is characterised by chronic hyperglycaemia [1]. This can cause end organ damage. The estimated worldwide diabetes prevalence for 2010...
Treatment of diabetic macular edema in vitrectomised eyes – comparison of intravitreal dexamethasone implant and posterior subtenon triamcinolone injection
3 April 2023
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Dexamethasone implant, Diabetic macular edema, Pars plana vitrectomy, Posterior subtenon triamcinolone
This retrospective study was aimed to compare intravitreal dexamethasone implant and posterior subtenon triamcinolone injection (PSTA) in the treatment of diabetic macular edema (DME) in vitrectomised eyes. Sixty-four (48.12%) patients who had received PSTA and 69 (51.88%) patients who had...
Intravitreal dexamethasone implant for diabetic macular oedema
1 February 2015
| Brian Ang
|
Paediatric Ophthalmology / Strabismus
The authors report on the three-year outcomes of the Ozurdex Dexamethasone (DEX) intravitreal implant multi-centre trial for the treatment of diabetic macular oedema (DME). Patients with DME (best-corrected vision of 20/50 to 20/200 and central retinal thickness of ≥300µm) were...
New sculpture unveiled at ABDO College
A new sculpture was unveiled at ABDO College this week.Macular oedema after cataract surgery in diabetic patients
1 December 2013
| Lorraine North
|
Retina / Uvea / Vitreous
The authors describe a multi-centre prospective observational study of 293 participants that underwent cataract surgery who all had diabetic retinopathy without definite central-involved macular oedema. Forty-five clinical sites took part throughout the United States. Patients were eligible if there was...
Multicentre PCO rates in different brands of monofocal intraocular lenses
5 October 2020
| Hadi Ziaei
|
Cataract and Refractive
This was a longitudinal, retrospective cohort study featuring 47,754 (three years) and 20,763 (five years) eyes with age-related (≥65 year) cataract surgeries between 2010-2013 across seven UK ophthalmology clinics. The three- and five-year incidence of posterior capsular opacification (PCO) and...
Demyelinating optic neuropathy
Introduction Optic neuritis (ON) is an inflammatory process affecting the optic nerve. After glaucoma, it is the most common optic neuropathy affecting patients under the age of 50. The usual presentation of typical ON is unilateral subacute loss of vision...Steroid treatment for pseudophakic cystoid macular oedema
1 October 2021
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Cystoid macular edema, intravitreal steroids, triamcinolone
The authors present a retrospective comparison of 45 eyes of 41 patients treated with 2mg intravitreal triamcinolone (IVT group) and 50 eyes of 42 patients treated with 40mg sub-Tenons triamcinolone (STT group) for pseudophakic cystoid macular oedema (CMO). The visual...
Steroid implants in the treatment of post-epiretinal membrane peel macular oedema
1 February 2018
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Central retinal thickness, Dexamethasone implant, Fluocinolone acetonide implant, Intravitreal steroid implants, Long-term outcome, Macular pucker surgery, Membrane peeling, Pars plana vitrectomy, Persistent macular edema
This is a retrospective review of 39 eyes of 37 patients treated with Ozurdex® (intravitreal dexamethasone implant) for persistent post-operative cystoid macular oedema (CMO) following vitrectomy and idiopathic epiretinal membrane (ERM) peeling. The 0.7mg implant was injected in each eye...